|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismProtein-protein interaction inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with PEP-Therapy SAS
0 Patents (Medical) associated with PEP-Therapy SAS
100 Deals associated with PEP-Therapy SAS
100 Translational Medicine associated with PEP-Therapy SAS